Overview

Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
This is a clinical trial assessing duloxetine compared with placebo in patients who have generalized anxiety disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride